Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

STAG2 Somatic Mutations Are Associated with Specific Dysplastic Megakaryocytic and Myeloid Cell Features in Myelodysplastic Syndrome

Waihay J Wong, Rebecca L. Zon, Caleb Ho, Olga Pozdnyakova, Donna S. Neuberg, Elisabeth M Battinelli, Marlise R. Luskin, Zuzana Tothova, Elizabeth A. Morgan, Christopher James Gibson, Benjamin L. Ebert

Blood (2023) 142 (Supplement 1): 3233.

https://doi.org/10.1182/blood-2023-187172

Published: 2023

Journal Articles

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

Blood (2023) 141 (15): 1817–1830.

https://doi.org/10.1182/blood.2022018246

Published: 2023

Includes: Supplemental data

Journal Articles

KLRG1 Depletion Is a Novel Therapeutic Strategy for Patients with Mature T and NK/T-Cell Lymphomas

Blood (2022) 140 (Supplement 1): 2253–2255.

https://doi.org/10.1182/blood-2022-162583

Published: 2022

Journal Articles

Clonal Hematopoiesis Evolves into Dendritic Cell Neoplasm through the Acquisition of UV Mutations in the Skin

Peter Van Galen, Gabriel K. Griffin, Christopher A.G. Booth, Katsuhiro Togami, Sun Sook Chung, Daniel Ssozi, Julia A. Verga, Juliette M.C. Bouyssou, Yoke Seng Lee, Vignesh Shanmugam, Nicole R. LeBoeuf, Elizabeth A. Morgan, Bradley E. Bernstein, Volker Hovestadt, Andrew A. Lane

Blood (2022) 140 (Supplement 1): 1998–1999.

https://doi.org/10.1182/blood-2022-163666

Published: 2022

Journal Articles

Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis

Blood (2020) 136 (26): 3051–3055.

https://doi.org/10.1182/blood.2020008206

Published: 2020

Includes: Supplemental data

Journal Articles

Male-Biased Spliceosome Mutations in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Impair pDC Activation and Apoptosis

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-137727

Published: 2020

Journal Articles

Clinical utility of targeted next-generation sequencing–based screening of peripheral blood in the evaluation of cytopenias

Vignesh Shanmugam, Aric Parnes, Rajeshwari Kalyanaraman, Elizabeth A. Morgan, Annette S. Kim

Blood (2019) 134 (24): 2222–2225.

https://doi.org/10.1182/blood.2019001610

Published: 2019

Includes: Supplemental data

Journal Articles

Talazoparib Treatment Preferentially Depletes Cohesin-Mutant Clones in New In Vivo M odels of Cohesin-Mutant Myeloid Diseases

Mounica Vallurupalli, MD, Rebecca Gorelov, BS, Jacqueline S Garcia, MD, Elizabeth A Morgan, MD, Benjamin Ebert, MD, Zuzana Tothova, MD PhD

Blood (2019) 134 (Supplement_1): 560.

https://doi.org/10.1182/blood-2019-130308

Published: 2019

Journal Articles

Targeted inhibition of CD47-SIRPα requires Fc-FcγR interactions to maximize activity in T-cell lymphomas

Salvia Jain, Alexandria Van Scoyk, Elizabeth A. Morgan, Andrew Matthews, Kristen Stevenson, Gail Newton, Foster Powers, Anu Autio, Abner Louissaint, Jr, Guillemette Pontini, Jon C. Aster, Francis W. Luscinskas, David M. Weinstock

Blood (2019) 134 (17): 1430–1440.

https://doi.org/10.1182/blood.2019001744

Published: 2019

Includes: Supplemental data

Journal Articles

Clinical Utility of Routine Targeted Next-Generation Sequencing of Peripheral Blood in the Evaluation of Patients with Cytopenias

Vignesh Shanmugam, MD, Aric Parnes, MD, Elizabeth A Morgan, MD, Annette S. Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3090.

https://doi.org/10.1182/blood-2018-99-117922

Published: 2018

Journal Articles

Developmental Ontogeny of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Revealed By Recurrent High Burden Clonal Hematopoiesis, Including in "Skin-Only" Disease

Gabriel K Griffin, MD, Katsuhiro Togami, MD PhD, Elizabeth A Morgan, MD, Andrew A. Lane, MD PhD

Blood (2018) 132 (Supplement 1): 2755.

https://doi.org/10.1182/blood-2018-99-119945

Published: 2018

Journal Articles

Targeted Inhibition of CD47-Sirp Alpha Requires Fc-Fc Gamma Receptor Interactions to Maximize Phagocytosis in T-Cell Lymphomas

Salvia Jain, MD, Alexandria Van Scoyk, Elizabeth A Morgan, MD, Andrew Matthews, MD, Kristen E. Stevenson, MS, Gail Newton, PhD, Anu K Autio, PhD, Marisa O. Peluso, MS, Rachel W O'Connor, BS, Alison M. Paterson, PhD, Pamela M. Holland, PhD, Francis W Luscinskas, PhD, David M Weinstock, MD

Blood (2018) 132 (Supplement 1): 339.

https://doi.org/10.1182/blood-2018-99-112986

Published: 2018

Journal Articles

Recurrent Genetic HLA Loss in Acute Myeloid Leukemia Relapsed after Matched Unrelated Allogeneic Hematopoietic Cell Transplant

Blood (2018) 132 (Supplement 1): 817.

https://doi.org/10.1182/blood-2018-99-113911

Published: 2018

Journal Articles

Clinical Characteristics of GNB1 and GNAS Mutations in an Unselected Cohort of 6,343 Patients with Hematologic Abnormalities

Rahul S. Vedula, MD, Marlise R. Luskin, MD, Kevin Copson, MA, Priti Kumari, M.S., Anne Charles, BS, Annette S. Kim, MD PhD, Elizabeth A Morgan, MD, Gregory A. Abel, MD MPH, Richard M. Stone, MD, Andrew A. Lane, MD PhD, R. Coleman Lindsley, MD, PhD

Blood (2018) 132 (Supplement 1): 1819.

https://doi.org/10.1182/blood-2018-99-118746

Published: 2018

Journal Articles

Next Generation Sequencing Identifies Smoldering Multiple Myeloma Patients with a High Risk of Disease Progression

Blood (2017) 130 (Supplement 1): 392.

https://doi.org/10.1182/blood.V130.Suppl_1.392.392

Published: 2017

Journal Articles

Systematic KIT Sequencing Identifies Unsuspected Systemic Mastocytosis with Associated Hematological Neoplasm

Elizabeth A Morgan, MD, Jeffrey W. Craig, MD PhD, Annette S. Kim, MDPhD, Geraldine S. Pinkus, Jon C. Aster, MD PhD, Frank C Kuo, MBBS, PhD, David P. Steensma, MD, R. Coleman Lindsley, MD PhD, Daniel J. DeAngelo, MD

Blood (2017) 130 (Supplement 1): 2923.

https://doi.org/10.1182/blood.V130.Suppl_1.2923.2923

Published: 2017

Journal Articles

Dual Conditional Loss of BLIMP-1 and p53 in B-Cells Drives B-Cell Lymphomagenesis

Antonio Sacco, BS, Yawara Kawano, MD PhD, Michele Moschetta, MD, Jihye Park, PhD, Oksana Zavidij, PhD, Michaela Reagan, PhD, Yuji Mishima, PhD, Elizabeth A. Morgan, MD, Satoshi Takagi, PhD, Salomon Manier, MD, Luisa Imberti, MD, Giuseppe Rossi, MD, Kwok Wong, MD, Ruben D. Carrasco, MD PhD, Irene M. Ghobrial, MD, Aldo M. Roccaro, MD PhD

Blood (2016) 128 (22): 4169.

https://doi.org/10.1182/blood.V128.22.4169.4169

Published: 2016

Journal Articles

T-Cell Lymphoma Patient-Derived Xenografts and Newly Developed Cell Lines Recapitulate Aspects of Disease Biology and Represent Novel Tools for Preclinical Drug Development

Blood (2016) 128 (22): 3015.

https://doi.org/10.1182/blood.V128.22.3015.3015

Published: 2016

Journal Articles

Systematic STAT3 Mutation Testing Identifies Patients with Unsuspected T-Cell Large Granular Lymphocytic Leukemia

Elizabeth A. Morgan, MD, Mark N. Lee, MD PhD, Daniel J. DeAngelo, MD PhD, David P. Steensma, MD, Richard M. Stone, MD, Frank C. Kuo, MD PhD, Jon C. Aster, MD PhD, Christopher J. Gibson, MD, R. Coleman Lindsley, MDPhD

Blood (2016) 128 (22): 919.

https://doi.org/10.1182/blood.V128.22.919.919

Published: 2016

Journal Articles

Generation of Models of Human Hematologic Malignancies Using CRISPR Genome Engineering

Zuzana Tothova, MD PhD, John M Krill-Burger, MCS, Katerina D Popova, BA, Quinlan Sievers, BA, David Yudovich, BSc, Roger Belizaire, MD PhD, Jon C. Aster, MD PhD, Elizabeth A. Morgan, MD, Aviad Tsherniak, MSc, Benjamin L Ebert, MD PhD

Blood (2016) 128 (22): 741.

https://doi.org/10.1182/blood.V128.22.741.741

Published: 2016

NARROW

STAG2 Somatic Mutations Are Associated with Specific Dysplastic Megakaryocytic and Myeloid Cell Features in Myelodysplastic Syndrome

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

KLRG1 Depletion Is a Novel Therapeutic Strategy for Patients with Mature T and NK/T-Cell Lymphomas

Clonal Hematopoiesis Evolves into Dendritic Cell Neoplasm through the Acquisition of UV Mutations in the Skin

Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis

Male-Biased Spliceosome Mutations in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Impair pDC Activation and Apoptosis

Clinical utility of targeted next-generation sequencing–based screening of peripheral blood in the evaluation of cytopenias

Talazoparib Treatment Preferentially Depletes Cohesin-Mutant Clones in New In Vivo M odels of Cohesin-Mutant Myeloid Diseases

Targeted inhibition of CD47-SIRPα requires Fc-FcγR interactions to maximize activity in T-cell lymphomas

Clinical Utility of Routine Targeted Next-Generation Sequencing of Peripheral Blood in the Evaluation of Patients with Cytopenias

Developmental Ontogeny of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Revealed By Recurrent High Burden Clonal Hematopoiesis, Including in "Skin-Only" Disease

Targeted Inhibition of CD47-Sirp Alpha Requires Fc-Fc Gamma Receptor Interactions to Maximize Phagocytosis in T-Cell Lymphomas

Recurrent Genetic HLA Loss in Acute Myeloid Leukemia Relapsed after Matched Unrelated Allogeneic Hematopoietic Cell Transplant

Clinical Characteristics of GNB1 and GNAS Mutations in an Unselected Cohort of 6,343 Patients with Hematologic Abnormalities

Next Generation Sequencing Identifies Smoldering Multiple Myeloma Patients with a High Risk of Disease Progression

Systematic KIT Sequencing Identifies Unsuspected Systemic Mastocytosis with Associated Hematological Neoplasm

Dual Conditional Loss of BLIMP-1 and p53 in B-Cells Drives B-Cell Lymphomagenesis

T-Cell Lymphoma Patient-Derived Xenografts and Newly Developed Cell Lines Recapitulate Aspects of Disease Biology and Represent Novel Tools for Preclinical Drug Development

Systematic STAT3 Mutation Testing Identifies Patients with Unsuspected T-Cell Large Granular Lymphocytic Leukemia

Generation of Models of Human Hematologic Malignancies Using CRISPR Genome Engineering

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only